i10 Productivity
Rankings

Johnson ScientistsMedical and Health Sciences / Pharmacy & Pharmaceutical Sciences i10 Productivity Rankings 2024

Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index"Also see: Universities Rankings 2024 (Sort by : Total i10 Index)  and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)

* Total i10 Index Rankings
World Rank
8,827
Country Rank
3,036
Institution Rank
36
United States
Julie A Johnson
pharmacogenetics
cardiovascular pharmacology
beta-blockers
warfarin
genomic medicine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
348
232
0.667
* Total i10 Index Rankings
World Rank
103,172
Country Rank
31,754
Institution Rank
19
United States
Honghui Zhou
pharmacokinetics/pharmacodynamics
drug-drug interaction
MIDD
QSP
clinical pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
104
68
0.654
* Total i10 Index Rankings
World Rank
135,434
Country Rank
40,644
Institution Rank
29
United States
Juan Jose Perez Ruixo|JJ Perez-Ruixo, JJP Ruixo
Clinical Pharmacology
Pharmacometrics
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
87
42
0.483
* Total i10 Index Rankings
World Rank
166,644
Country Rank
48,964
Institution Rank
35
United States
İtalo Poggesi
clinical pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
31
0.413
* Total i10 Index Rankings
World Rank
189,113
Country Rank
54,810
Institution Rank
38
United States
Amarnath Sharma
Clinical Pharmacology
Pharmaceutics
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
68
35
0.515
* Total i10 Index Rankings
World Rank
280,614
Country Rank
78,075
Institution Rank
60
United States
Willem Talloen
Early development clinical trial design
Biomarkers
Statistical bio-informatics
omics data analysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
49
28
0.571
* Total i10 Index Rankings
World Rank
309,063
Country Rank
84,950
Institution Rank
71
United States
Tc Sarich
cardiovascular
metabolic disease
RWE
digital health
thrombosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
18
0.400
* Total i10 Index Rankings
World Rank
309,190
Country Rank
84,977
Institution Rank
72
United States
Shane Kavanagh
health economics
epidemiology
real world evidence
outcomes research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
45
17
0.378
* Total i10 Index Rankings
World Rank
313,667
Country Rank
86,180
Institution Rank
73
United States
Wim Van Der Elst
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
33
0.750
* Total i10 Index Rankings
World Rank
319,937
Country Rank
87,788
Institution Rank
78
United States
Weirong Wang
drug development
PK/PD model
QSP
clinical pharmacology
therapeutic biologics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
36
0.837
* Total i10 Index Rankings
World Rank
320,737
Country Rank
88,001
Institution Rank
79
United States
Justin Scheer
Gene Therapy and Gene Delivery
Drug Discovery
T-cell Engagers
Immuno-Oncology
Protein Engineering
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
34
0.791
* Total i10 Index Rankings
World Rank
327,732
Country Rank
89,743
Institution Rank
80
United States
Jack Sheehan
Diabetes
CNS
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
36
0.857
* Total i10 Index Rankings
World Rank
331,115
Country Rank
90,530
Institution Rank
87
United States
Peter N Johnson
pediatric pharmacy
sedation and analgesia
drug withdrawal
pharmacokinetic alterations in obesity
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
25
0.595
* Total i10 Index Rankings
World Rank
338,119
Country Rank
92,355
Institution Rank
82
United States
Mahesh N Samtani
Clinical Pharmacology & Pharmacometrics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
41
29
0.707
* Total i10 Index Rankings
World Rank
357,203
Country Rank
97,090
Institution Rank
86
United States
Jeffrey W Clymer
Pharmacology
Pharmaceutics
Surgical Medical Devices
Genomics
Statistics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
39
24
0.615
* Total i10 Index Rankings
World Rank
360,406
Country Rank
97,831
Institution Rank
87
United States
Yue Guo
Pharmaceutical Sciences
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
38
37
0.974
* Total i10 Index Rankings
World Rank
370,983
Country Rank
100,517
Institution Rank
92
United States
Michela Capello
Cancer Research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
34
0.919
* Total i10 Index Rankings
World Rank
377,511
Country Rank
102,117
Institution Rank
94
United States
John Lee
CAR-T
Cell Therapy
Gene Editing
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
37
18
0.486
* Total i10 Index Rankings
World Rank
381,941
Country Rank
103,309
Institution Rank
96
United States
Ranjeet Dash
Pharmacokinetics
Drug Metabolism
PK PD
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
36
32
0.889
* Total i10 Index Rankings
World Rank
393,936
Country Rank
106,361
Institution Rank
100
United States
Bevan Emma Huang
statistical genetics
precision medicine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
35
28
0.800
* Total i10 Index Rankings
World Rank
420,551
Country Rank
112,962
Institution Rank
103
United States
Jamese Hilliard
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
18
0.545
* Total i10 Index Rankings
World Rank
426,773
Country Rank
114,625
Institution Rank
108
United States
Jong Bong Lee
Clinical Pharmacology and Pharmacometrics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
28
0.875
* Total i10 Index Rankings
World Rank
427,915
Country Rank
114,881
Institution Rank
109
United States
Ivo Cornelissen
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
26
0.813
* Total i10 Index Rankings
World Rank
429,374
Country Rank
115,282
Institution Rank
111
United States
Weixuan Chen
Protiomics
Post translational modification
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
24
0.750
* Total i10 Index Rankings
World Rank
433,569
Country Rank
1,168
Institution Rank
32
Nigeria
Onyenmechi Johnson Afonne
Environmental/Heavy Metal Toxicology
Reproductive Toxicology
Risk Assessment
Pharmacokinetics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
32
15
0.469
Total i10 Index AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 i10 Index Metrics
University Rank Country Rank Region Rank World Rank Name Country University / Institution Subject
Research Areas
Total Last 6 Year Last 6 year/total
36 3,036 3,373 8,827 United States United States University of Florida University of Florida Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacogenetics | cardiovascular pharmacology | beta-blockers | warfarin | genomic medicine |

348 232 0.667
19 31,754 36,169 103,172 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacokinetics/pharmacodynamics | drug-drug interaction | MIDD | QSP | clinical pharmacology |

104 68 0.654
29 40,644 46,367 135,434 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmacometrics | Drug Development |

87 42 0.483
35 48,964 55,921 166,644 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

clinical pharmacology |

75 31 0.413
38 54,810 62,555 189,113 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmaceutics | Drug Development |

68 35 0.515
60 78,075 88,964 280,614 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Early development clinical trial design | Biomarkers | Statistical bio-informatics | omics data analysis |

49 28 0.571
71 84,950 96,763 309,063 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

cardiovascular | metabolic disease | RWE | digital health | thrombosis |

45 18 0.400
72 84,977 96,791 309,190 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

health economics | epidemiology | real world evidence | outcomes research |

45 17 0.378
73 86,180 98,136 313,667 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

44 33 0.750
78 87,788 99,952 319,937 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

drug development | PK/PD model | QSP | clinical pharmacology | therapeutic biologics |

43 36 0.837
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
79 88,001 100,196 320,737 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Gene Therapy and Gene Delivery | Drug Discovery | T-cell Engagers | Immuno-Oncology | Protein Engineering |

43 34 0.791
80 89,743 102,157 327,732 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Diabetes | CNS |

42 36 0.857
87 90,530 103,057 331,115 United States United States University of Oklahoma Health Sciences Center University of Oklahoma Health Sciences Center Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pediatric pharmacy | sedation and analgesia | drug withdrawal | pharmacokinetic alterations in obesity |

42 25 0.595
82 92,355 105,115 338,119 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology & Pharmacometrics |

41 29 0.707
86 97,090 110,438 357,203 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacology | Pharmaceutics | Surgical Medical Devices | Genomics | Statistics |

39 24 0.615
87 97,831 111,273 360,406 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceutical Sciences |

38 37 0.974
92 100,517 114,288 370,983 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Cancer Research |

37 34 0.919
94 102,117 116,086 377,511 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

CAR-T | Cell Therapy | Gene Editing |

37 18 0.486
96 103,309 117,428 381,941 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacokinetics | Drug Metabolism | PK PD |

36 32 0.889
100 106,361 120,846 393,936 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

statistical genetics | precision medicine |

35 28 0.800
103 112,962 128,229 420,551 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

33 18 0.545
108 114,625 130,092 426,773 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology and Pharmacometrics |

32 28 0.875
109 114,881 130,385 427,915 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Oncology |

32 26 0.813
111 115,282 130,826 429,374 United States United States Johnson & Johnson Co. Johnson & Johnson Co. Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Protiomics | Post translational modification | Drug discovery |

32 24 0.750
32 1,168 7,944 433,569 Nigeria Nigeria Nnamdi Azikiwe University Nnamdi Azikiwe University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Environmental/Heavy Metal Toxicology | Reproductive Toxicology | Risk Assessment | Pharmacokinetics |

32 15 0.469